| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/24/2015 | US8962064 Production of pulverulent coating compositions for stable protective coatings for pharmaceutical dosage forms |
| 02/24/2015 | US8962063 Methods and systems for dosing and coating inhalation powders onto carrier particles |
| 02/24/2015 | US8962058 High-potency sweetener composition with antioxidant and compositions sweetened therewith |
| 02/24/2015 | US8962040 Vaporized medicants and methods of use |
| 02/24/2015 | US8962039 Method of treatment of neurodegenerative or neuro-muscular degenerative diseases and therapeutic agent to treat the same |
| 02/24/2015 | US8962036 Disintegrable formulations of lanthanum carbonate |
| 02/24/2015 | US8962033 Method for improved fibrin sealing |
| 02/24/2015 | US8962032 Modulator |
| 02/24/2015 | US8962031 Super paramagnetic iron oxide nanoparticles with metallic coatings and a method of synthesizing the same |
| 02/24/2015 | US8962030 Nanoparticles for delivery of active agents |
| 02/24/2015 | US8962029 Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications |
| 02/24/2015 | US8962028 Topical steroid composition and method |
| 02/24/2015 | US8962027 Materials comprising water-soluble polymer particles and methods of making and using them |
| 02/24/2015 | US8962026 Nanoemulsion therapeutic compositions and methods of using the same |
| 02/24/2015 | US8962025 Rapidly acting dry sealant and methods for use and manufacture |
| 02/24/2015 | US8962024 Method for treating primary insomnia |
| 02/24/2015 | US8962023 UV cured gel and method of making |
| 02/24/2015 | US8962022 Pharmaceutical compositions comprising an active substance from the substituted benzhydrylpiperazine family |
| 02/24/2015 | US8962021 Solid pharmaceutical composition comprising telithromycin |
| 02/24/2015 | US8962020 Long-acting and controlled release formulations of 2-[(3-chlorophenyl) amino] phenylacetic acid |
| 02/24/2015 | US8962019 Sustained drug release composition |
| 02/24/2015 | US8962018 Oral formulation of anhydrous olanzapine form I |
| 02/24/2015 | US8962017 Formulation of silymarin with high efficacy and prolonged action and the preparation method thereof |
| 02/24/2015 | US8962016 Extended release dosage forms of metoprolol |
| 02/24/2015 | US8962015 Orally bioavailable lipid-based constructs |
| 02/24/2015 | US8962014 Transdermal therapeutic system for administering rivastigmine or derivatives thereof |
| 02/24/2015 | US8962013 Multi-layered transdermal system with triazine UV absorber |
| 02/24/2015 | US8962012 Nonaqueous pressure-sensitive adhesive for medicinal tape preparation for percutaneous absorption, medicinal tape preparation for percutaneous absorption, and process for producing the same |
| 02/24/2015 | US8962011 Process and intra-cervical device for the local release of drugs in the local-regional treatment of cervical cancer |
| 02/24/2015 | US8962010 Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs |
| 02/24/2015 | US8962009 Sustained release intraocular implants and related methods |
| 02/24/2015 | US8962005 Gastric reflux resistant dosage forms |
| 02/24/2015 | US8962004 Encapsulated triazinyl sulfonylurea herbicide and methods of use |
| 02/24/2015 | US8962002 Alloplastic injectable dermal filler and methods of use thereof |
| 02/24/2015 | US8962001 Nuclease inhibitors and methods for their use |
| 02/24/2015 | US8962000 Microemulsion and sub-micron emulsion process and compositions |
| 02/24/2015 | US8961999 Methods and compositions for bone formation |
| 02/24/2015 | US8961964 High concentration antibody and protein formulations |
| 02/24/2015 | US8961958 High concentration self-microemulsifying coenzyme Q10 preparations for nutritional use |
| 02/24/2015 | US8961936 Ultrasonography using time- and temperature-sensitive variable adhesion coupling gels |
| 02/24/2015 | US8961917 Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use |
| 02/24/2015 | US8961501 Method for applying flowable hydrogels to a cornea |
| 02/24/2015 | US8961498 Electronic pill comprising a plurality of medicine reservoirs |
| 02/24/2015 | US8961492 System and method for controlling the iontophoretic delivery of therapeutic agents based on user inhalation |
| 02/24/2015 | US8961477 Delivery of immune response modifier compounds |
| 02/24/2015 | US8961391 Systems and methods for delivery of a therapeutic agent |
| 02/24/2015 | US8960128 Topical anesthetic composition |
| 02/24/2015 | CA2684977C A method for the production of adsorbates of a rasagiline salt having a water-soluble adjuvant |
| 02/24/2015 | CA2616508C Pharmaceutical formulation of nitrooxyderivatives of nsaids |
| 02/24/2015 | CA2608226C Dried formulations of nanoparticle-coated capsules |
| 02/24/2015 | CA2507522C Oral drug delivery system |
| 02/19/2015 | WO2015023889A1 Rapidly-dissolving thin film formulation of water soluble digitalis glycoside for the treatment of congestive heart disease |
| 02/19/2015 | WO2015023884A2 Timed release of substances to treat ocular disorders |
| 02/19/2015 | WO2015023797A1 Lipophilic nanoparticles for drug delivery |
| 02/19/2015 | WO2015023796A2 Peptide conjugated particles |
| 02/19/2015 | WO2015023770A1 Methods for fine particle manufacture |
| 02/19/2015 | WO2015023767A1 Calcium formate as a supplement to prevent neural tube defects |
| 02/19/2015 | WO2015023715A1 Nanozymes, methods of making nanozymes, and methods of using nanozymes |
| 02/19/2015 | WO2015023704A1 Extruded immediate release abuse deterrent pill |
| 02/19/2015 | WO2015023697A1 Method for treating otic infections after tympanostomy tube placement |
| 02/19/2015 | WO2015023675A2 Extruded immediate release abuse deterrent pill |
| 02/19/2015 | WO2015023601A1 Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery |
| 02/19/2015 | WO2015023600A1 Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery |
| 02/19/2015 | WO2015023557A1 Device and method for sustained release of low water solubility therapeutic agent in solubilizer |
| 02/19/2015 | WO2015022944A1 Method for reducing surface free energy and composition having reduced surface free energy |
| 02/19/2015 | WO2015022874A1 Hydrogen-containing antimicrobial agent |
| 02/19/2015 | WO2015022560A1 Stable pharmaceutical composition containing bisoprolol and ramipril |
| 02/19/2015 | WO2015022559A1 Pharmaceutical composition containing rosuvastatin and ramipril |
| 02/19/2015 | WO2015022454A1 Novel self-emulsifying instant solid system made from cyclodextrins and oil(s) for oral administration |
| 02/19/2015 | WO2015022349A1 Dosage form comprising enzalutamide |
| 02/19/2015 | WO2015022348A1 Preparation for protection against extrinsic and intrinsic skin aging |
| 02/19/2015 | WO2015022204A1 Coating composition |
| 02/19/2015 | WO2015021949A1 A thermodynamically stable solid solution of agomelatine for use in a pharmaceutical formulation |
| 02/19/2015 | WO2015021861A1 Stable insulin secretagogue peptide hydro-injection pharmaceutical composition |
| 02/19/2015 | WO2015021704A1 Uses of doxycycline for preparing antitumor drugs |
| 02/19/2015 | WO2015021530A1 Antiviral methods and compositions comprising probiotic bacterial molecules |
| 02/19/2015 | WO2015003659A9 Traditional chinese medicine composition, and preparation and application thereof |
| 02/19/2015 | WO2014194429A9 Targeted enzyme compounds and uses thereof |
| 02/19/2015 | WO2014190440A9 Abuse deterrent immediate release formulation |
| 02/19/2015 | WO2014173941A9 Method for obtaining a stable gel of hyaluronic acid and of a free form of vitamin c and/or a salt thereof |
| 02/19/2015 | US20150051589 Capsule type medical device and medical system |
| 02/19/2015 | US20150051559 Transdermal patch for treatment of dementia or alzheimer type dementia |
| 02/19/2015 | US20150051558 Composition and method for corneal proliferation |
| 02/19/2015 | US20150051539 Method of a Pharmaceutical Delivery System for Use Within a Joint Replacement |
| 02/19/2015 | US20150051441 Embryo implantation |
| 02/19/2015 | US20150051292 Amantadine compositions and methods of use |
| 02/19/2015 | US20150051289 Liquid formulations of hypoglycaemic sulfonamides |
| 02/19/2015 | US20150051223 Method of using diketopiperazines and composition containing them |
| 02/19/2015 | US20150051216 Oral spray formulations and methods for administration of sildenafil |
| 02/19/2015 | US20150051192 Blocking of cue-induced drug reinstatement |
| 02/19/2015 | US20150051184 High-purity large-scale preparation of stannsoporfin |
| 02/19/2015 | US20150051181 Process for producing nanoparticles laden with active ingredient |
| 02/19/2015 | US20150051143 Compositions and methods for treating non-alcoholic steatohepatitis |
| 02/19/2015 | US20150051139 Mucins as Antiviral Compounds |
| 02/19/2015 | US20150050499 Fibrosis causing agent |
| 02/19/2015 | US20150050497 Nicotinamide powder and process and device for its production |
| 02/19/2015 | US20150050416 Coated Solid Dosage Forms |
| 02/19/2015 | US20150050357 Nanoparticle isoflavone compositions & methods of making and using the same |
| 02/19/2015 | US20150050356 Nanoparticle comprising rapamycin and albumin as anticancer agent |
| 02/19/2015 | US20150050354 Modified polynucleotides for the treatment of otic diseases and conditions |